Silvercrest Asset Management Group LLC Abbott Laboratories Transaction History
Silvercrest Asset Management Group LLC
- $14.7 Billion
- Q3 2025
A detailed history of Silvercrest Asset Management Group LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 1,169,554 shares of ABT stock, worth $152 Million. This represents 1.07% of its overall portfolio holdings.
Number of Shares
1,169,554
Previous 1,210,052
3.35%
Holding current value
$152 Million
Previous $165 Million
4.82%
% of portfolio
1.07%
Previous 1.12%
Shares
34 transactions
Others Institutions Holding ABT
# of Institutions
3,652Shares Held
1.38BCall Options Held
10.3MPut Options Held
9.01M-
Vanguard Group Inc Valley Forge, PA173MShares$22.5 Billion0.36% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.1 Billion0.31% of portfolio
-
State Street Corp Boston, MA78.2MShares$10.2 Billion0.37% of portfolio
-
Capital International Investors Los Angeles, CA61.6MShares$8.01 Billion1.4% of portfolio
-
Capital Research Global Investors Los Angeles, CA38.8MShares$5.04 Billion1.02% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $228B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...